Latest Form 144 filings
Officers, directors and other affiliates of a company file Form 144 when they place an order to sell restricted or control shares, if they plan to sell more than 5,000 shares or more than $50,000 worth within three months. It is a notice of a planned sale; officers and directors report the sale itself later on Form 4. 13D, 13G and Form 144 explained
Form 144 notices
Newest first. When a Form 144/A amends a notice, only the amendment is listed.
Filed in the last 365 days (US Eastern dates).
Form 144 filings on Livermore: Jan 4, 2023 to Sep 29, 2026.
Notices with a clearly misreported market value are left out of this list and its totals; they still appear, flagged, on the company's page. A value counts as misreported when the price per share it implies is far above the company's prices in Form 4 trades and 13F filings around the planned sale date.
- Notices
- 125
- Market value to sell
- $155.1M
- Sellers
- 24
- Companies
- 13
- Under 10b5-1 plans
- 82
| Company | Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|---|
| VGNTVersigent PLC | Sep 8, 20266:28 PM ET | Kevin ClarkOfficer | 220.0K | $10.4M | Sep 8, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Sep 8, 20262:28 PM ET | Najat KhanOfficer | 22.4K | $78.8K | Sep 8, 202610b5-1 | Merrill Lynch | SEC |
| RSIRush Street Interactive, Inc. | Sep 3, 202611:04 AM ET | Sauers KyleOfficer | 23.0K | $610.9K | Sep 3, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Sep 1, 20264:21 PM ET | Borgeson BlakeDirector | 30.0K | $100.2K | Sep 1, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Aug 21, 202611:27 AM ET | Gibson ChristopherFormer director | 77.3K | $262.0K | Aug 21, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Aug 20, 202611:32 AM ET | Gibson ChristopherFormer director | 75.0K | $255.0K | Aug 20, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Aug 19, 202611:54 AM ET | Gibson ChristopherFormer director | 100.0K | $327.5K | Aug 19, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Aug 18, 20265:14 PM ET | Gibson ChristopherFormer director | 26.8K | $80.4K | Aug 18, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Aug 13, 202612:58 PM ET | Gibson ChristopherFormer director | 100.0K | $331.0K | Aug 13, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Aug 12, 202611:56 AM ET | Gibson ChristopherFormer director | 50.0K | $168.5K | Aug 12, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Aug 10, 20264:59 PM ET | Gibson ChristopherFormer director | 100.0K | $326.8K | Aug 10, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Aug 7, 202612:42 PM ET | Gibson ChristopherFormer director | 100.0K | $325.4K | Aug 7, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Aug 4, 20261:37 PM ET | Borgeson BlakeDirector | 30.0K | $97.5K | Aug 4, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Aug 4, 202610:35 AM ET | Gibson ChristopherFormer director | 75.0K | $244.9K | Aug 4, 2026 | Fidelity Brokerage Services LLC | SEC |
| RSIRush Street Interactive, Inc. | Aug 3, 20264:29 PM ET | Lori R Schwartz 2025 Gift Trust U/Adtd 03/28/2025Director · Officer | 166.7K | $4.48M | Aug 3, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| RSIRush Street Interactive, Inc. | Aug 3, 20264:27 PM ET | Richard T Schwartz Revocable Trust U/A DTD 10/25/2024Director · Officer | 141.7K | $3.81M | Aug 3, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| RSIRush Street Interactive, Inc. | Aug 3, 20264:26 PM ET | Richard T Schwartz 2024 Gift Trust U/A DTD 10/25/2024Director · Officer | 166.7K | $4.48M | Aug 3, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| RSIRush Street Interactive, Inc. | Aug 3, 202610:27 AM ET | Sauers KyleOfficer | 23.0K | $613.0K | Aug 3, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jul 30, 20264:10 PM ET | Gibson ChristopherFormer director | 75.0K | $225.0K | Jul 30, 2026 | Fidelity Brokerage Services LLC | SEC |
| GOOGAlphabet Inc. | Jul 29, 20264:20 PM ET | Marsida SaraciOfficer | 449 | $149.3K | Jul 29, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jul 29, 20264:09 PM ET | Gibson ChristopherFormer director | 50.0K | $151.4K | Jul 29, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jul 27, 20264:16 PM ET | Gibson ChristopherFormer director | 50.0K | $152.7K | Jul 27, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jul 21, 20264:11 PM ET | Gibson ChristopherFormer director | 100.0K | $304.3K | Jul 21, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jul 20, 20264:11 PM ET | Gibson ChristopherFormer director | 100.0K | $289.8K | Jul 20, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jul 17, 20264:10 PM ET | Gibson ChristopherFormer director | 100.0K | $296.7K | Jul 17, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jul 16, 20264:13 PM ET | Gibson ChristopherFormer director | 100.0K | $311.1K | Jul 16, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jul 15, 20264:12 PM ET | Gibson ChristopherFormer director | 123.3K | $410.3K | Jul 15, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jul 14, 20264:07 PM ET | Gibson ChristopherFormer director | 100.0K | $330.5K | Jul 14, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jul 13, 20264:32 PM ET | Gibson ChristopherFormer director | 100.0K | $343.0K | Jul 13, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jul 10, 20264:09 PM ET | Gibson ChristopherFormer director | 100.0K | $353.6K | Jul 10, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jul 9, 20264:26 PM ET | Gibson ChristopherFormer director | 286.0K | $1.09M | Jul 9, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jul 8, 20264:26 PM ET | Gibson ChristopherFormer director | 200.0K | $737.7K | Jul 8, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jul 7, 20261:39 PM ET | Gibson ChristopherFormer director | 250.0K | $987.5K | Jul 7, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jul 7, 202611:36 AM ET | Borgeson BlakeDirector | 40.0K | $158.5K | Jul 7, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jul 6, 20263:28 PM ET | Gibson ChristopherFormer director | 100.0K | $378.0K | Jul 6, 2026 | Fidelity Brokerage Services LLC | SEC |
| RSIRush Street Interactive, Inc. | Jul 6, 202610:07 AM ET | Sauers KyleOfficer | 23.0K | $725.2K | Jul 6, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jul 2, 202612:54 PM ET | Gibson ChristopherFormer director | 100.0K | $374.5K | Jul 2, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jul 1, 20265:19 PM ET | Gibson ChristopherFormer director | 100.0K | $366.6K | Jul 1, 2026 | Fidelity Brokerage Services LLC | SEC |
| RSIRush Street Interactive, Inc. | Jul 1, 20264:49 PM ET | Sona Trust U/A DTD 05/09/2025Officer | 60.0K | $1.78M | Jul 1, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Orion Diversified Holding Co., IncCommon | Jun 30, 20263:25 PM ET | Lull Thomas RyanOfficer | 118.8K | $41.6K | Jun 22, 2026 | OCOF Securities Limited | SEC |
| GOOGAlphabet Inc. | Jun 26, 20264:31 PM ET | Marsida SaraciOfficer | 449 | $153.6K | Jun 26, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| RSIRush Street Interactive, Inc. | Jun 25, 20263:17 PM ET | Wierbicki PaulOfficer · Director | 10.0K | $301.2K | Jun 25, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jun 18, 20264:33 PM ET | Gibson ChristopherDirector | 300.4K | $962.3K | Jun 18, 2026 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jun 18, 20269:44 AM ET | Bumpus NamandjeDirector | 3.96K | $12.6K | Jun 18, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jun 18, 20269:37 AM ET | Gibson ChristopherDirector | 40.0K | $127.2K | Jun 18, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jun 5, 20261:29 PM ET | Najat KhanOfficer | 23.6K | $84.5K | Jun 5, 202610b5-1 | Merrill Lynch | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jun 5, 202610:19 AM ET | Gibson ChristopherDirector | 40.0K | $144.8K | Jun 5, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| RSIRush Street Interactive, Inc. | Jun 3, 202611:20 AM ET | Sauers KyleOfficer | 23.0K | $585.1K | Jun 3, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Jun 3, 202610:16 AM ET | Bumpus NamandjeDirector | 4.39K | $15.5K | Jun 3, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| LEALear Corp | Jun 2, 202611:39 AM ET | Orsini Frank COfficer | 5.00K | $742.5K | Jun 2, 2026 | Fidelity Brokerage Services LLC | SEC |